BLOOMFIELD, N.J.--(BUSINESS WIRE)--Alfacell Corporation (Nasdaq: ACEL), a biopharmaceutical company focused on the discovery, development and commercialization of novel ribonuclease (RNase) therapeutics for cancer and other life-threatening diseases, today announced that Andrew Aromando, Senior Vice President, Commercial Development and Operations, is scheduled to present at the C.E. Unterberg, Towbin Life Sciences Conference at The Palace Hotel in New York at 9:00 AM EST on Tuesday, October 31. The presentation will be accessible live via Wall Street Webcasting at http://www.wsw.com/webcast/ceut5/acel/ and will be available for replay.
